Reference-scaled Bioequivalence [RSABE / ABEL]

posted by AngusMcLean – USA, 2014-03-28 18:48 (4476 d 20:37 ago) – Posting: # 12735
Views: 5,076

http://screencast.com/t/dAkRl2NyPwe

I am reading the review paper of Barbara Davit published in Pharm. Research 2013. I have a comprehension problem

See link ABOVE to view the equation towards the top of the page.
It is evident that when σWR=σ W0 then the BE limits are the usual ±Ln 1.25 ie. (1.25, 0.8)
I want to use the equation to evaluate an example of the implied limits when σWR>σ W0 and I selected an example from the paper of σWR =0.7565. σ W0 is set at 0.25 by the Agency.
I am having difficulty following this equation and implementing it. I try and evaluate the right hand side of the equation towards the top of the page in the link attached
Ln (1.25) σWR/σ W0
As I read this equation I am thinking it is Ln(1.25)0.7565/0.25 =0.223*0.7565/0.25 = 0.6747
Or is it in the LN scale
Ln[(1.25) σWR/σ W0]= Ln 3.7825
Please can I be advised as to the evaluation of the right hand side of the equation; also I am interested how one arrives at the evaluation of the left hand side of the equation with the σWR and σ W0 is give.

Angus

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
282 visitors (0 registered, 282 guests [including 21 identified bots]).
Forum time: 16:26 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5